Wallenstam AB (publ) (LON:0R7Y)
41.38
+0.62 (1.52%)
At close: Dec 30, 2025
Wallenstam AB Market Cap
Wallenstam AB has a market cap or net worth of 2.11 billion as of January 2, 2026. Its market cap has decreased by -8.58% in one year.
Market Cap
2.11B
Enterprise Value
4.85B
Revenue
241.51M
Ranking
n/a
PE Ratio
14.25
Stock Price
41.38
Market Cap Chart
Since March 1, 1996, Wallenstam AB's market cap has increased from 69.57M to 2.11B, an increase of 2,933.00%. That is a compound annual growth rate of 12.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 2.11B | -1.49% |
| Dec 30, 2025 | 2.14B | -5.62% |
| Dec 30, 2024 | 2.27B | -19.06% |
| Dec 29, 2023 | 2.80B | 21.54% |
| Dec 30, 2022 | 2.31B | -49.20% |
| Dec 30, 2021 | 4.54B | 19.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.22B |
| HSBC Holdings | 201.57B |
| Shell | 156.37B |
| Unilever | 107.52B |
| Rio Tinto Group | 102.69B |
| Rolls-Royce Holdings | 96.51B |
| British American Tobacco p.l.c. | 91.15B |
| GSK plc | 73.45B |